Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations
Clinical trial NCT02982889 · COMPLETED
Trial details
- NCT number
- NCT02982889
- Sponsor
- Liquidia Technologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2017-03-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.